摘要
Abstract
Objective :To describe the clinical and myocardial enzyme characteristics of neonatal hyperbilirubi ‐nemia after treatment using diagnostic standard of pathologic jaundice or hour‐bilirubin . Methods :A descriptive study was carried out by reviewing the clinical files containing side‐effect ,TB ,AST ,LDH ,CK and CK‐MB of neo‐natal who were diagnosed hyperbilirubinemia .Neonatal diagnosed pathological jaundice allocated to control group . Neonatal diagnosed using hour‐bilirubin allocated to experimental group .Results :The experimental group was ad‐mitted to hospital more early (t= 3 .49 , P< 0 .05) .Two groups of children with TB ,AST ,LDH ,CK and CK‐MB on admission were lower after treatment (P < 0 .05) .The experimental group was lower than control group of TB , AST ,CK and LDH on admitting (P< 0 .05) .However ,there was no statistical significance of CK‐MB value (P> 0 . 05) .Conclusion :Our results revealed that it can effectively reduce the value of myocardial enzyme with reference to the concept of the hour‐bilirubin to diagnosis and treatment .关键词
黄疸 ,新生儿/治疗/黄疸 ,新生儿/血液/胆红素/代谢/乳酸脱氢酶/代谢Key words
Jaundice/neonatal/therapy Jaundice/neonatal/blood Bilirubin/metabolism Lactate dehydrogen-ase/ metabolism分类
医药卫生
